Search details
1.
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.
Cancer
; 129(14): 2245-2255, 2023 07 15.
Article
in English
| MEDLINE | ID: mdl-37081608
2.
SIRT1 activates the expression of fetal hemoglobin genes.
Am J Hematol
; 92(11): 1177-1186, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28776729
3.
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.
Neuro Oncol
; 25(7): 1331-1342, 2023 Jul 06.
Article
in English
| MEDLINE | ID: mdl-36541551
4.
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Neoplasia
; 35: 100846, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36335802
5.
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312).
Clin Cancer Res
; 26(6): 1213-1219, 2020 03 15.
Article
in English
| MEDLINE | ID: mdl-31857431
6.
Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium.
Neuro Oncol
; 22(1): 163-165, 2020 01 11.
Article
in English
| MEDLINE | ID: mdl-31613963
Results
1 -
6
de 6
1
Next >
>>